The Grand Solutions committee for Life Science, Health and Welfare Technology

We use artificial intelligence (AI) to translate the content on our website. This web page has been machine translated. If there are any uncertainties, please refer to the Danish text.

The innovation fund's board has set up four Grand Solutions committees, each with its own thematic focus, including the Grand Solutions committee for life-science, health and welfare technology, which consists of 12 members including a chairperson.

 

The committee is composed of six impact experts who have the skills to assess the commercial and strategic potential of Grand Solutions' applications for Denmark and six international established researchers who have the skills to assess the quality of the applications' research and innovation at an international level.

 

All members possess solid and extensive knowledge and recent experience in one or more specific professional areas that relate to the committee's theme, including the following domains:

  • Stem cell research and technology
  • Development of medicines
  • Clinical outcome and economic impact of whole genome sequencing
  • Development of personalized medicine
  • Development of medical equipment
  • Application of artificial intelligence within Life Science and welfare technology
  • Insight into the Danish health system, including the development, testing and application of welfare technology within, among other things, the elderly, social and health areas
  • Digital prevention and treatment services for people with mental disorders
  • Social science and/or humanistic approaches, e.g. with a view to qualifying needs analyses, implementation processes and contextualisation of health and illness behaviour.

The list is not exhaustive.

 

The subject areas reflect the political priorities under which Innovation Fund Denmark distributes funds, and which are decided annually in connection with the adoption of the annual Finance Act.

 

The overall committee has also been set up with a focus on ensuring diversity in both societal and professional terms.

Committee members:

Peter Herskind (chairperson)
VP. Product Design & Engineering, Coloplast, Copenhagen

Jai Prakash (deputy chair)
Professor, Engineered Therapeutics, University of Twente, NL

Carsten Gram Hansen
Reader, Institute for Regeneration and Repair, The University of Edinburgh, GB-SCT

Charlotte Vedel
Experienced Senior Executive, Advisor and Board Member, Copenhagen

Egon Toft
Head of Research, Aalborg University Hospital, Aalborg

Eugenia Carvalho
Principal Investigator, Center for Neuroscience and Cell Biology, University of Coimbra, PT

Ilmo Keskimäki
Professor, The Finnish Institute for Health and Welfare, Finland & Tampere University, FI

Jens C. Brüning
Professor, Max Planck Institute for Metabolism Research, Germany, DE

Katrine Thor Andersen
Founder & Principal, Bering Impact LLC, Seattle, WA

Marilisa Boffo
Associate Professor of Clinical Psychology and Digital Behavioral Health, Erasmus University Rotterdam

Nazarena Mazzaro
VP Global R&D, ATOS Medical, Lyngby

Trine Rolighed Thomsen
Project Director in Healthcare Technology, Technological Institute, Aarhus

Wim H. van Harten
Professor, The Netherlands Cancer Institute, NL

TBA (To Be Announced)

Terms of reference
Download terms of reference
Open section, Download terms of reference

The detailed criteria for appointing the committee's members, chairman and deputy chairman appear in the committee's terms of reference.

 

Documents